1. Home
  2. FTRE vs WOR Comparison

FTRE vs WOR Comparison

Compare FTRE & WOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • WOR
  • Stock Information
  • Founded
  • FTRE 1996
  • WOR 1955
  • Country
  • FTRE United States
  • WOR United States
  • Employees
  • FTRE N/A
  • WOR N/A
  • Industry
  • FTRE Medical Specialities
  • WOR Aerospace
  • Sector
  • FTRE Health Care
  • WOR Consumer Discretionary
  • Exchange
  • FTRE Nasdaq
  • WOR Nasdaq
  • Market Cap
  • FTRE 1.9B
  • WOR 2.0B
  • IPO Year
  • FTRE N/A
  • WOR N/A
  • Fundamental
  • Price
  • FTRE $19.34
  • WOR $43.47
  • Analyst Decision
  • FTRE Hold
  • WOR Sell
  • Analyst Count
  • FTRE 11
  • WOR 2
  • Target Price
  • FTRE $23.30
  • WOR $44.50
  • AVG Volume (30 Days)
  • FTRE 1.2M
  • WOR 171.1K
  • Earning Date
  • FTRE 11-08-2024
  • WOR 12-17-2024
  • Dividend Yield
  • FTRE N/A
  • WOR 1.79%
  • EPS Growth
  • FTRE N/A
  • WOR N/A
  • EPS
  • FTRE N/A
  • WOR 0.77
  • Revenue
  • FTRE $2,975,600,000.00
  • WOR $1,191,093,000.00
  • Revenue This Year
  • FTRE N/A
  • WOR N/A
  • Revenue Next Year
  • FTRE $1.23
  • WOR $4.03
  • P/E Ratio
  • FTRE N/A
  • WOR $49.88
  • Revenue Growth
  • FTRE 2.80
  • WOR 270.19
  • 52 Week Low
  • FTRE $16.53
  • WOR $37.91
  • 52 Week High
  • FTRE $41.02
  • WOR $69.96
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 46.40
  • WOR 61.92
  • Support Level
  • FTRE $19.44
  • WOR $37.88
  • Resistance Level
  • FTRE $20.86
  • WOR $42.35
  • Average True Range (ATR)
  • FTRE 1.45
  • WOR 1.12
  • MACD
  • FTRE -0.29
  • WOR 0.01
  • Stochastic Oscillator
  • FTRE 13.39
  • WOR 67.56

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.

Share on Social Networks: